FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022608255> ?p ?o ?g. }

• W2022608255 endingPage "479" @default.
• W2022608255 startingPage "473" @default.
• W2022608255 abstract "We reported in the first part of this editorial [1] and in an article on AIDS therapy with five HIV1 virostatics applied in two then three, or initially three, or initially four agent combinations, given in 3 week sequences differing from each other due to drug rotation [2], the contrast between: a) the decrease of viral load, possibly below the detectable level, b) the absence of effect on the helper CD4+, the CD8+ C57− cytotoxics and the CD8+ C57+ suppressor cells. We proposed a thesis according to which the HIV1-AIDS complex might have another pathogenic component other than HIV1, ie, a microchimerism graft-versus-host reaction (GvH) or an autologous GvH-like reaction [1]. Shifting from five to 10 virostatics owing to the availability of lamivudine or 3TC [3], stavudine or d4T [4] and three HIV1 protease inhibitors, saquinavir [5], ritonavir [6] and indinavir [7], applied according to the same modality, we have enhanced the reduction of viral load, and significantly decreased the CD8+ C57+ suppressor cell counts, and increased those of the CD8+ C57− cytotoxic cells. This result which indirectly shows the role of HIV1 in the increase of suppressor CD8+ cells, hence in the late loss pf immune memory and of opportunistic infections [8], reinforces the thesis of a role, in AIDS pathogenesis, of a latent GvH reaction activated by HIV, primo-infection, and its evolution from the hyperplastic phase to the hypoplastic one, which, inducing severe immune suppression, is responsible for HIV1 active infection relapse after the so-called latent phase [1]. Hence the proposition we make, of an indication of CD4 modulation with non specific immunotherapy by bestatin [9], of which we showed the effect in another population of HIV1-AIDS complex patients [10]. Its effect can be potentiated by tuftsin [11, 12]. When the suppressor cell number goes up over that of the cytotoxic one after the HIV, active infection relapse, Interferon y could be added, which, by amplifying the CD28 pathway [13] on CD8+ cytotoxics, while suppressor cells lack CD28 [14], which might reestablish a ratio of suppressor over cytotoxic cells nearer to normal. It remains that the role of the five secondarily included agents in the decrease of suppressor cells will only be attributed with certainty and entirely to their virostatic effect, if it is shown that none of them exerts a selective anti-suppressor cell action." @default.
• W2022608255 created "2016-06-24" @default.
• W2022608255 creator A5035496673 @default.
• W2022608255 creator A5042647863 @default.
• W2022608255 creator A5053844997 @default.
• W2022608255 creator A5065946606 @default.
• W2022608255 creator A5080259363 @default.
• W2022608255 date "1996-01-01" @default.
• W2022608255 modified "2023-09-23" @default.
• W2022608255 title "Will killing the last HIV1 particle cure AIDS patients? II: Second part. Decrease of viral load and of T-suppressor cells, and increase of the cytotoxic cells, without effect on CD4, after the use of 10 virostatics applied in 3 or 4 drug combinations of different sequences. The time for CD4 immunotherapy?" @default.
• W2022608255 cites W1592092257 @default.
• W2022608255 cites W1963799542 @default.
• W2022608255 cites W1969673324 @default.
• W2022608255 cites W1973398091 @default.
• W2022608255 cites W1988796037 @default.
• W2022608255 cites W1990698709 @default.
• W2022608255 cites W2002688672 @default.
• W2022608255 cites W2013068560 @default.
• W2022608255 cites W2013533833 @default.
• W2022608255 cites W2025693221 @default.
• W2022608255 cites W2029780606 @default.
• W2022608255 cites W2033667917 @default.
• W2022608255 cites W2040962830 @default.
• W2022608255 cites W2050381744 @default.
• W2022608255 cites W2061199281 @default.
• W2022608255 cites W2077277569 @default.
• W2022608255 cites W2077640396 @default.
• W2022608255 cites W2081064796 @default.
• W2022608255 cites W2085459671 @default.
• W2022608255 cites W2086186867 @default.
• W2022608255 cites W2090457538 @default.
• W2022608255 cites W2118690112 @default.
• W2022608255 cites W2142526560 @default.
• W2022608255 cites W2158803760 @default.
• W2022608255 cites W2160885872 @default.
• W2022608255 cites W2170109565 @default.
• W2022608255 cites W2318087828 @default.
• W2022608255 cites W2339057709 @default.
• W2022608255 cites W2407207450 @default.
• W2022608255 doi "https://doi.org/10.1016/s0753-3322(97)89277-3" @default.
• W2022608255 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9091060" @default.
• W2022608255 hasPublicationYear "1996" @default.
• W2022608255 type Work @default.
• W2022608255 sameAs 2022608255 @default.
• W2022608255 citedByCount "6" @default.
• W2022608255 crossrefType "journal-article" @default.
• W2022608255 hasAuthorship W2022608255A5035496673 @default.
• W2022608255 hasAuthorship W2022608255A5042647863 @default.
• W2022608255 hasAuthorship W2022608255A5053844997 @default.
• W2022608255 hasAuthorship W2022608255A5065946606 @default.
• W2022608255 hasAuthorship W2022608255A5080259363 @default.
• W2022608255 hasConcept C142462285 @default.
• W2022608255 hasConcept C154317977 @default.
• W2022608255 hasConcept C159047783 @default.
• W2022608255 hasConcept C167672396 @default.
• W2022608255 hasConcept C202751555 @default.
• W2022608255 hasConcept C203014093 @default.
• W2022608255 hasConcept C2522874641 @default.
• W2022608255 hasConcept C2777210460 @default.
• W2022608255 hasConcept C2779298103 @default.
• W2022608255 hasConcept C2780252810 @default.
• W2022608255 hasConcept C2993143319 @default.
• W2022608255 hasConcept C54355233 @default.
• W2022608255 hasConcept C71924100 @default.
• W2022608255 hasConcept C86803240 @default.
• W2022608255 hasConcept C8891405 @default.
• W2022608255 hasConceptScore W2022608255C142462285 @default.
• W2022608255 hasConceptScore W2022608255C154317977 @default.
• W2022608255 hasConceptScore W2022608255C159047783 @default.
• W2022608255 hasConceptScore W2022608255C167672396 @default.
• W2022608255 hasConceptScore W2022608255C202751555 @default.
• W2022608255 hasConceptScore W2022608255C203014093 @default.
• W2022608255 hasConceptScore W2022608255C2522874641 @default.
• W2022608255 hasConceptScore W2022608255C2777210460 @default.
• W2022608255 hasConceptScore W2022608255C2779298103 @default.
• W2022608255 hasConceptScore W2022608255C2780252810 @default.
• W2022608255 hasConceptScore W2022608255C2993143319 @default.
• W2022608255 hasConceptScore W2022608255C54355233 @default.
• W2022608255 hasConceptScore W2022608255C71924100 @default.
• W2022608255 hasConceptScore W2022608255C86803240 @default.
• W2022608255 hasConceptScore W2022608255C8891405 @default.
• W2022608255 hasIssue "10" @default.
• W2022608255 hasLocation W20226082551 @default.
• W2022608255 hasLocation W20226082552 @default.
• W2022608255 hasOpenAccess W2022608255 @default.
• W2022608255 hasPrimaryLocation W20226082551 @default.
• W2022608255 hasRelatedWork W1764055327 @default.
• W2022608255 hasRelatedWork W1968472624 @default.
• W2022608255 hasRelatedWork W2044066378 @default.
• W2022608255 hasRelatedWork W2106121570 @default.
• W2022608255 hasRelatedWork W2136175148 @default.
• W2022608255 hasRelatedWork W2163500912 @default.
• W2022608255 hasRelatedWork W2314026148 @default.
• W2022608255 hasRelatedWork W2411865776 @default.
• W2022608255 hasRelatedWork W4301456881 @default.
• W2022608255 hasRelatedWork W4302402797 @default.
• W2022608255 hasVolume "50" @default.
• W2022608255 isParatext "false" @default.

• next